From mboxrd@z Thu Jan 1 00:00:00 1970 Path: main.gmane.org!not-for-mail From: dogen@netposta.net Newsgroups: gmane.emacs.bugs,gmane.spam.detected Subject: (OTCBB: WSCH) Special Investment Update Date: Thu, 11 Apr 2002 04:12:04 -1900 Sender: bug-gnu-emacs-admin@gnu.org Message-ID: NNTP-Posting-Host: localhost.gmane.org Mime-Version: 1.0 Content-Type: text/html; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable X-Trace: main.gmane.org 1018523593 25212 127.0.0.1 (11 Apr 2002 11:13:13 GMT) X-Complaints-To: usenet@main.gmane.org NNTP-Posting-Date: Thu, 11 Apr 2002 11:13:13 +0000 (UTC) Return-path: Original-Received: from fencepost.gnu.org ([199.232.76.164]) by main.gmane.org with esmtp (Exim 3.33 #1 (Debian)) id 16vcVs-0006YX-00 for ; Thu, 11 Apr 2002 13:13:13 +0200 Original-Received: from localhost ([127.0.0.1] helo=fencepost.gnu.org) by fencepost.gnu.org with esmtp (Exim 3.34 #1 (Debian)) id 16vcUz-0000rG-00; Thu, 11 Apr 2002 07:12:17 -0400 Original-Received: from [210.113.239.129] (helo=mail.yujinco.co.kr) by fencepost.gnu.org with esmtp (Exim 3.34 #1 (Debian)) id 16vcRm-00009T-00; Thu, 11 Apr 2002 07:08:58 -0400 Original-Received: from pop.Atlas.cz ([63.233.4.114]) by mail.yujinco.co.kr (8.9.3/8.9.3) with ESMTP id UAA25597; Thu, 11 Apr 2002 20:15:46 +0900 Original-To: X-RBL-Warning: (relays.ordb.org) Your mailserver is an open relay -- see Errors-To: bug-gnu-emacs-admin@gnu.org X-BeenThere: bug-gnu-emacs@gnu.org X-Mailman-Version: 2.0.9 Precedence: bulk List-Help: List-Post: List-Subscribe: , List-Id: Bug reports for GNU Emacs, the Swiss army knife of text editors List-Unsubscribe: , List-Archive: Xref: main.gmane.org gmane.emacs.bugs:558 gmane.spam.detected:15389 X-Report-Unspam: http://unspam.gmane.org/gmane.emacs.bugs:558 Investors

This message has been = sent to you in compliance with our strict anti-abuse regulations. We will co= ntinue to bring you valuable offers on the products and services that i= nterest you most. If you do not wish to receive further mailings, please= click below.   You may then rest-assured that you will never= receive another email from us again.  We respect all removal requests.= UNSUBSCRIBE ME P= LEASE . This message was sent by World Reach Corporation.  This m= essage is an advertisement.  Copyright 2000, 2001, 2002 all rights= reserved.

Wall Street Stockwatch
Wasatch P= harmaceuticals: Company Update


Special Corporate Update WSCH
Company Name &n= bsp; Wasatch Pharmaceutic= als (OTCBB: WSCH)
Current Price= $0.007
52-Week High<= /TD> $1.95
52-Week Low $0.0045

News from Wasatch Pharmaceuti= cal (OTCBB: WSCH) is hard to come by lately.  Gary Heesch, CEO = of Wasatch, doesn't buy the idea that a press release every day is produ= ctive.  He feels "it is usually perceived as an effort to over- p= romote the stock."  But what about the future of WSCH?&nbs= p; Why should anyone buy or hold their stock with no news?

Mr. Heesch feels that = past news releases and their record of Company accomplishments speak f= or themselves.  For example, Wasatch, now in its 18th year of research, has produced skin care products for the treatment of most common= skin disorders. This puts them years ahead of the competiti= on.

In the last 12 months, WSCH h= as addressed a whole new dimension in preparation for launching its pr= oducts into the worldwide marketplace, so that millions of peop= le will finally have access to therapies that allow them to remedy t= heir skin disorders and live more normal lives. This preparation = involved:

(1) A new management team with impressive individual = records of creating billions of dollars in revenue for Oracle, Bausc= h & Lomb, and Warner Lambert.

(2) The establishment of a new AISC Distribution Cent= er that is fully inventoried with products ready for shipment.

(3) Establishing beautiful corporate offices separate= from the company's clinic.

(4) Relocation of the American Institue of Skin Care = clinic to a facility designed to be the prototype for future clinic= s.

To cap off the last 12 months, patents were filed for fiv= e new products that will be packaged and ready for release to = physicians and hospitals this year.  All of these accomplishments = translate into a variety of activites and relationships that will i= nsure the growth and stability of WSCH.

When pressed to reveal this year's plans, Mr. Heesch wants t= o reserve the substance of these activities until they are completed a= nd tucked away.  He did say that existing activities and plan= s include the acquisition of existing medical clinics, ongoing = discussion for foreign licensing, conversations with groups of p= hysicians that can represent as many as 2,000 physicians converting= their patients to Wasatch products for their skin care problem= s, and also a possible merger that will expand WSCH's= sphere of influence in the medical community.  

As these activities come to fruition, they will be di= sclosed to WSCH shareholders and the public in detail. Unlike many c= ompanies struggling with today's economy, Wasatch Pharmaceutical i= s alive and well and working towards a productive future.

Stay tuned for plenty more to come from WSCH.

To be removed from future mailings, plea= se respond
to this email with "Remove" in the subject line


DISCLAIMER: 
Information within this email contains "forward looking statem= ents" within the meaning of Section 27A of the Securities Act of 193= 3 and Section 21B of the Securities Exchange Act of 1934. Any statem= ents that express or involve discussions with respect to prediction= s, expectations, beliefs, plans, projections, objectives, goals, assumptions or= future events or performance are not statements of historical fact an= d may be "forward looking statements."

Forward looking statements are based on expectations, estimate= s and projections at the time the statements are made that involve a= number of risks and uncertainties which could cause actual resul= ts or events to differ materially from those presently anticipated. = Forward looking statements in this action may be identified through th= e use of words such as "projects", "foresee", "expects", "will,"&nbs= p; "anticipates," "estimates," "believes," "understands" or that by statements i= ndicating certain actions "may," "could," or "might" occur.  All in= formation provided within this email pertaining to investing, stocks, se= curities must be understood as information provided and not investment = advice. Emerging Growth Stock Alert advises all readers and subscriber= s to seek advice from a registered professional securities rep= resentative before deciding to trade in stocks featured within this email.=   None of the material within this report shall be construed as = any kind of investment advice.

In compliance with the Securities Act of 1933, Section17(b), Emerg= ing Growth Stock Alert discloses the receipt of ten million unrestrict= ed shares of WSCH from a third party for the publication of this report and = additional services related to WSCH. Be aware of an inherent conflict of interest resu= lting from such compensation due to our intent to profit from the sale o= f these shares.  All factual information in this report was gath= ered from public sources, including but not limited to SEC filings, Com= pany Press Releases, and the company's website at wasatchpharm.com. Emerging Growth Stock Alert= believes this information to be reliable but can make no guarantee as to it= s accuracy or completeness. Use of the material within this email constitutes= your acceptance of these terms.

 

 
 
This message has been = sent to you in compliance with our strict anti-abuse regulations. We will = continue to bring you valuable offers on the products and services that= interest you most. If you do not wish to receive further mailings, plea= se click below.   You may then rest-assured that you will nev= er receive another email from us again.  We respect all removal requests. <= a href=3D"http://www.monsterstocks.net/removeme.html">UNSUBSCRIBE ME P= LEASE . This message was sent by World Reach Corporation.  This= message is an advertisement.  Copyright 2000, 2001, 2002 all righ= ts reserved
=